from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1776c/-

LFCtreatmentdescriptionclass of inhibitor

0.363

Amikacinug/mL Amikacintranslation

0.263

Cap5-10ug/mL Capreomycintranslation

-0.505

Rox10-50 ug/mL Roxithromycintranslation

-0.206

SM2-5 ug/mL Streptomycintranslation

0.189

Tet5-10 ug/mL Tetracyclinetranslation

0.488

Rif0.2-5ug/mL Rifampicintranscription

0.454

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.050

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.563

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.222

CPZ10-50 ug/mL Chlorpromazinerespiration

0.704

Clofazimine10-13 ug/mL Clofaziminerespiration

0.191

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.853

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.411

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.061

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.186

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.104

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.653

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.306

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.969

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.416

KCN5-20 ug/mL Potassium cyaniderespiration

-0.475

NaN30.2-2 mM Sodium aziderespiration

-0.706

Nigericin50 uM Nigericinrespiration

0.844

TRC10-150 ug/mL Triclosanrespiration

0.344

TRZ10-25 ug/mL Thioridazinerespiration

-1.246

Valinomycin0.5-10 uM Valinomycinrespiration

-0.062

ZnSO42 mM ZnSO4respiration

0.272

menadione6-10 ug/mL Menadionerespiration

0.643

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.360

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.634

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.535

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.257

NRP_1Non-replicating persistence stage 1dosRassociated

-0.233

Amp0.2mg/mL AmpicillincellWall

0.336

Cephalexin20-100 ug/mL CephalexincellWall

0.887

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.343

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.154

EMB10-20 ug/mL EthambutolcellWall

0.032

Eta12-40 ug/mL EthionamidecellWall

-0.211

INH0.2-0.4 ug/mL IsoniazidcellWall

0.299

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.770

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.719

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.097

BZA0.12 mg/mL BenzamidearomaticAmides

-0.049

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.305

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.443

H2O24 mM hydrogen peroxideDNAdamaging

0.287

Levo10 ug/mL LevofloxacinDNAdamaging

-0.079

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.110

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.097

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.454

UVUV-irradiationDNAdamaging

-0.020

ARP41-4 ug/mL Antitubercular compound ARP4?

0.565

Antimycin12.5-50 ug/mL Antimycin A?

-2.363

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.874

PA_110-50 ug/mL Antitubercular compound PA-1?

0.572

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.077

PA8240.2-2 ug/mL PA-824?

0.230

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.983

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-2.134

Verapamil50 uM Verapamil?

-1.734

mercaptoethanol2 mM 2-Mercaptoethanol?

-2.229

methoxatin10-20 ug/mL Methoxatin?